21 funding opportunities found in this category. Change the order of results: Newest First Oldest First Expiring Soonest Expiring Latest Lowest Award to Highest Highest Award to Lowest
Scholarships for the 8th Biennial Conference - Cancer, Culture & Literacy: Advancing Communications
CCL Conference Dates Conference Date: May 17 – 19, 2012 Pre-conference workshops: May 17, 2012 Main Conference: May 17 – 19, 2012
The Cancer, Culture and Literacy Conference offers extraordinary networking and learning opportunities for individuals wanting to learn more about the roles of culture, language and literacy in cancer health disparities and in the design, implementation and evaluation of cancer communications, programs and educational interventions. Hosted by Moffitt Cancer Center, the conference provides a national forum for the exchange and dissemination of information covering current research, innovative communications, novel training programs, and emerging education practices.
This three-day conference offers a number of interactive activities including pre-conference skill-building workshops, plenary and breakout sessions, breakfast roundtables and a poster session. The conference curriculum features community-based participatory research (CBPR) approaches and qualitative methods to inform the development of cancer education media/materials and intervention design.
Conference participants include healthcare professionals, community health workers, advocates and survivors involved in developing cancer communications, innovative materials/media, educational programs and interventions that are tailored to cultural, linguistic and literacy needs of community members, Patients and cancer survivors. A variety of professional accreditation and continuing education contact hours will be offered.
The conference facilitates our understanding of cancer awareness and educational needs in diverse social, cultural, and literacy contexts. Ultimately, the goal is for attendees to incorporate culture and literacy components into the development of their communications, research, educational and outreach programs.
In an effort to assist conference registrants who have limited funding to attend conferences, we are able to offer some scholarships. The application process is online and opens on January 18, 2012.
Opens: January 18, 2012, 8:00am EST. Closes: March 5, 2012, 5:00pm EST.
Notifications will be made: March 16, 2012
Conference Contacts
Mailing address:
Moffitt Cancer Center Attn: Cindy Burcham 12902 Magnolia Drive, FOW-EDU Tampa, FL 33612
Email address: CCL2012@moffitt.org
Phone number: 813-745-6031
Course Director: Cathy D. Meade, PhD, RN, FAAN
Conference Planner: Chrystyna Pospolyta, MPH
Call for Applications: 2012 Raymond and Maria Floyd Award for Bladder Cancer Research
The Bladder Cancer Advocacy Network (BCAN) is pleased to announce that we are now accepting applications for the 2012 Raymond and Maria Floyd Award for Bladder Cancer Research. This award is made possible by World Golf Hall of Famer Raymond Floyd and his wife, Maria, who have made a six-figure gift to the organization in support of advancing necessary research efforts to help those who have been profoundly affected by bladder cancer, the nation’s 5th most common form of cancer.
This $25,000 grant will cover direct costs associated with a one year bladder cancer-specific research proposal. The purpose of this grant is to advance research that will increase the understanding of bladder cancer risk, biology, prevention, and treatment while encouraging young investigators to pursue a career in bladder cancer research.
BCAN is eager to review all qualified applications, and we encourage you to distribute this grant information to any young researchers interested in investigating bladder cancer.
At the time the application is submitted, applicant must be a resident, graduate student, clinical research fellow, post-doctoral fellow, or junior faculty at an academic facility, teaching hospital or research institution at the time of application. Faculty members are eligible if within the first 5 years of faculty appointment.
The project must be bladder cancer-specific.
Completed applications must be submitted electronically to grants@bcan.org by March 29, 2012. The grant recipient will then be determined by a selection committee comprised of physicians and research specialists in bladder cancer. The award will be announced on or before May 19, 2012, and the grant period will begin on July 15, 2012. The grant recipient will be expected to present results at BCAN’s annual Bladder Cancer Think Tank Meeting in August, 2013.
Please contact BCAN if you have any questions. You can reach us at grants@bcan.org.
Call for Applications: Orthopaedic Research and Education Foundation Prospective Clinical Research Grant in Spine Care
Applications due March 8, 2012
Spine surgeons who are board-certified in neurosurgery and/or orthopaedic surgery are invited to apply for up to $300,000 ($50,000-$100,000 per year for up to three years) in grant support to further the work of individual investigators, investigator networks, single institutions, or consortia of institutions conducting prospective clinical research. Grants will in spine care in any of the following study areas:
spinal deformity—adult deformity outcomes, spondylolisthesis, pediatric scoliosis, pediatric kyphosis, and early onset scoliosis; spine trauma—epidemiology, process and outcomes of spinal injuries, surgical treatment of acute spinal cord injury); degenerative spinal disorders—prospective outcomes for surgical and non-surgical treatments of lumbar, cervical, and thoracic degenerative spinal disorders; spinal oncology (epidemiology, process and outcomes of primary and metastatic spinal tumors);and non-surgical interventions for the treatment of spine injuries and disorders, including diagnostic, public health and rehabilitative methodologies.
Grants will be awarded to qualified recipients based on satisfaction of published eligibility and application requirements, and independent peer review. Peer review teams of spine surgeons and spine care investigators will be assembled by OREF and directed by OREF’s Advisory Committee on Clinical Research in Spine Care in accordance with OREF peer review standards and procedures, comprising neurosurgeons and orthopaedic surgeons who are appointed solely by OREF. Completed applications are due to OREF by March 8, 2012, funding to begin May 1, 2012.
These grants are made possible by support from Medtronic Sofamor Danek, USA, Inc. As is the case for all OREF donors, Medtronic has no influence on disbursement or management of funds; the composition OREF staff or its board or committees; content of program communications; any aspect of grant administration, application review or selection of funded proposals/recipients; conduct of program activities; or dissemination of findings from funded projects.
For more information please contact:
Jean McGuire, V.P., Grants (847) 384-4348 Mary Marino, Grants Administrator (847) 384-4359
Request for Applications: Prostate Cancer Foundation-Honorable A. David Mazzone Special Challenge Award Research Program 2012
The Prostate Cancer Foundation (PCF) is pleased to announce the PCF-Honorable A. David Mazzone Special Challenge Award Research Program 2012.
These two-year awards will provide a total of $1 million per team. Challenge Awards support large-scale research projects. Proposals must be from teams of at least 3 highly experienced investigators capable of providing unique scientific expertise to the solution of a significant problem in prostate cancer research. A team may be assembled from one institution, or several institutions, from across the globe.
These awards focus on funding Treatment Sciences: Investigations of new ideas in man or laboratory support of a high impact clinical investigation.
IMPORTANT:
The online application submission form will go live at www.pcfscience.org after February 15, 2012.
The deadline for application submission is March 16, 2012.
Dr. Howard R. Soule Executive Vice President Chief Science Officer Prostate Cancer Foundation 1250 4th Street Santa Monica, CA 90401
Damon Runyon Clinical Investigator Award
Application deadline date for this award: February 15, 2012
The Damon Runyon Clinical Investigator Award supports young physician-scientists conducting patient-oriented cancer research. The goal is to increase the number of physicians capable of moving seamlessly between the laboratory and the patient’s bedside in search of breakthrough treatments.
The Clinical Investigator Award responds to three recognized realities:
Though there has never been a more pressing need or more promising time for clinical cancer research, fewer young physicians enter this area of investigation every year. The number of institutions committed to training young physicians in the scientific discipline and methodologies of clinical investigation is critically low. The burden of medical school debt (averaging over $100,000) discourages many physicians from pursuing clinical investigation.
The Damon Runyon Cancer Research Foundation’s award offers solutions to these realities. The awardee will receive financial support for three years, as well as assistance with certain research costs such as the purchase of equipment. The Foundation will also retire up to $100,000 of any medical school debt still owed by the awardee.
Building on the long-term success of the Damon Runyon Postdoctoral Fellowships, the creation of the Clinical Investigator Award is a logical extension of the Foundation’s overall mission to defeat cancer. The Clinical Investigator Award program is specifically intended to provide outstanding young physicians with the resources and training structure essential to becoming successful clinical investigators.
Definition of Clinical Research
For the purposes of this award, the Foundation’s definition of clinical research will follow the definition set out in “The NIH Director’s Panel on Clinical Research Report to The Advisory Committee to The NIH Director,” December, 1997.
a) Patient-oriented research: Research conducted with human subjects (or on material of human origin such as tissues, specimens and cognitive phenomena) for which an investigator directly interacts with human subjects. This area of research includes: patient-based studies of mechanisms of human disease, diagnostic and therapeutic interventions, clinical trials and development of new technologies for the detection, treatment and prevention of human cancers. b) Epidemiologic and behavioral studies. c) Outcomes research and health services research.
Excluded from this definition are in vitro studies that utilize human tissues but do not deal directly with patients. In other words, clinical or patient-oriented research is research in which it is necessary to know the identity of the patient(s) from whom the cells or tissues under study are derived.
Preference will be given to research that adheres to the “Handshake Rule,” meaning that the physician will conduct research studies that directly involve patients.
Partnership with NIH and NCI
Damon Runyon has a novel partnership with the National Institutes of Health (NIH) and the National Cancer Institute (NCI), which uniquely opens access to the NIH Clinical Center (CC) to Damon Runyon Clinical Investigators. The goal of this partnership is to use the special talent, expertise and resources of the participants to undertake pilot studies of specific diseases and to develop collaborative partnerships that accelerate clinical and translational cancer research, and thereby improve human health.
Potential opportunities for pilot partnership:
1. Damon Runyon Clinical Investigator Award applicants may apply with a mentor or co-mentor from NCI or another NIH Institute. The proposal must identify the research to be done at and resources to be used at the NIH CC.
2. Current Damon Runyon Clinical Investigators may conduct a research project at the NIH CC in collaboration with an NIH tenured/tenure-track investigator. The Damon Runyon Clinical Investigator would be the PI or co-PI on the project.
3. Current Damon Runyon Clinical Investigators may request to use the special equipment or facilities at the NIH CC, which could provide opportunities for investigators that may not be possible in their home institutions. Examples are: obtaining research materials such as research PET ligands or products from the CC Good Manufacturing Practice (GMP) facilities, or accessing other non patient-related activities/facilities. No NIH scientist collaboration would be required.
Please contact the Foundation’s Chief Scientific Officer, Yung Lie, with any questions regarding NIH/NCI partnership opportunities (212.455.0521).
Research, Training and Development
During each year of the award, the applicant must commit a minimum of 80% of their full-time professional effort to the conduct of research and research career development.
The Mentor’s role is to foster the development of the applicant’s knowledge, technical and analytical skills, and capacity for scientific inquiry in the field of human disease-oriented clinical and translational research. The Mentor also acts as an advocate for the applicant at the departmental, institutional, and professional levels. Selection and Review
The Clinical Investigator Award Committee (CIAC) will review applications and select awardees for approval by the Damon Runyon Cancer Research Foundation's Board of Directors. CIAC puts a premium on innovation and creativity when reviewing applications.
Selection Criteria
Excellence of the applicant and mentor. Innovation, creativity, quality and originality of the research proposal. The commitment of the mentor and institution to the development and training of the applicant as a skilled clinical research investigator. Evidence of the applicant’s commitment to clinical translational and/or cancer prevention research and their ability to apply advances in laboratory research to clinical problems. Importance of the proposed research to the field of cancer and/or cancer prevention. Adherence of the proposal to the definition of clinical research as set out on this web page. Adherence to the “Handshake Rule.”
Program Sponsors
Under the leadership of the Damon Runyon Cancer Research Foundation, the Clinical Investigator Award is funded in part through Accelerating Cancer Cures, a collaboration of the biopharmaceutical industry, academia and young researchers formed to achieve breakthroughs against cancer by rebuilding the ranks of brilliant and committed clinical investigators who can translate science into cures. Members include: Eli Lilly and Company, Celgene, Merck, Millennium: The Takeda Oncology Company, Pfizer and The Pharmaceutical Research and Manufacturers of America (PhRMA).
Eligibility
The applicant must be a U.S. citizen or permanent legal resident. Each applicant must be nominated by his/her institution. Applications will only be accepted from institutions that have been invited to submit them by the Foundation http://www.damonrunyon.org/for_scientists/more/invited_institutions/
Three (3) nominations per institution, including its affiliated schools, will be accepted. Because of its number of affiliated hospitals, Harvard Medical School may submit up to six (6) nominations.
The applicant must have received an MD or MD/PhD degree(s) from an accredited institution and be board-eligible.
The applicant may apply within the first four (4) years of his/her initial full faculty appointment after the final year of his/her subspecialty training (Adjunct or acting positions are not eligible).
Candidates may apply up to three times during this eligibility period. Candidates holding or awarded R01s at the time of application are not eligible to apply.
The applicant must commit to spending 80% of their time conducting research.
The applicant is required to apply in conjunction with a Mentor who is established in the field of clinical translational cancer research, cancer prevention and/or epidemiology and can provide the critical guidance needed during the period of the award. No more than two Damon Runyon Clinical Investigators will be funded to work with the same Mentor at any given time.
Funding
The $450,000 award will be for a period of three years. Funding in the amount of $150,000 will be allocated to the awardee’s institution each year for the support of the Clinical Investigator. Funds are intended to be flexible and can be used for a variety of scientific needs including the Investigator’s stipend and/or fringe benefits (up to $100,000), salaries for professional and technical personnel, special equipment, supplies and other miscellaneous items required to conduct the proposed research. No part of this grant can be used for indirect costs or institutional overhead.
Other Funding
Investigators may receive funding from other sources to support their research. However, no other physician-scientist career development award from a private source (non-federal government) may be held concurrently with the Clinical Investigator Award.
Physician-scientist career development awards from the federal government including the National Institutes of Health (e.g., K-08, K-12, K-23), the Department of Defense, and the U.S. Department of Veterans Affairs are allowed.
Scientific or budgetary overlap with other funded projects is not allowed. Therefore, it is critical that all current and pending grant support for your research be reported to the Foundation and the relationship of that support to the Damon Runyon funded project be explained.
Examples of awards that cannot be held concurrently with the Damon Runyon Clinical Investigator Award include (but are not limited to):
AACR- Career Development Award American Cancer Society- Mentored Research Scholar Grants in Applied and Clinical Research ASCO- Career Development Award Burroughs Wellcome Fund- Career Award for Medical Scientists Doris Duke Charitable Foundation- Clinical Scientist Development Award Howard Hughes Medical Institute- Physician-Scientists Early Career Award, Early Career Scientist Competition Kimmel Foundation- Kimmel Translation Science Award, Kimmel Scholar Award Leukemia and Lymphoma Society- Career Development Program, Scholar Awards
Please contact the Foundation with any questions regarding concurrent funding (212.455.0520). Debt Repayment Program
The Damon Runyon Cancer Research Foundation will retire up to $100,000 of any qualifying medical school debt still owed by the awardee.
Contact Information: Award Programs | 212.455.0520 | awards@damonrunyon.org
Funderburg Research Award in Gastric Cancer
One award is made to support the research of an established investigator working on novel approaches to gastric cancer.
AT A GLANCE Eligibility: Established Investigators Total Amount: $100,000 Amount per year: $50,000 Duration: 2 years Deadline: Aug. 31 Start Date: Jan. 1
DESCRIPTION This award provides $50,000 per year for two years (total $100,000) to an established investigator working on novel approaches in gastric cancer research, including the fields of gastric mucosal cell biology; regeneration and regulation of cell growth (not as they relate to peptic ulcer disease or repair); inflammation (including Helicobacter pylori) as precancerous lesions; genetics of gastric carcinoma; oncogenes in gastric epithelial malignancies; epidemiology of gastric cancer; etiology of gastric epithelial malignancies; or clinical research in the diagnosis or treatment of gastric carcinoma.
OBJECTIVE The overall objective of this award is to support an established investigator in the field of gastric biology whose research will enhance the fundamental understanding of gastric cancer pathobiology in order to ultimately prevent or develop a cure for the disease.
ELIGIBILITY Candidates for this award must hold a full-time faculty position at an accredited North American institution and must be established as an independent investigator in the field of gastric biology.
Women and minority investigators are strongly encouraged to apply.
AGA membership is required at the time of application submission. Please visit www.gastro.org/membership or call 301-654-2055, extension 651, for membership information.
REQUIREMENTS A letter of recommendation should be provided by the division chief or chair of the department of medicine and should outline support of the candidate and his/her research program.
Funds are to be used for the salary support, equipment and supplies of the investigator to promote his/her research. Indirect costs are not allowed.
Upon receipt of award notification, the recipient must provide institutional approval from the appropriate committee for use of human subjects or animals. If approval is not necessary, the recipient must provide an explanation. Annually, a one-page plain-language progress report, a scientific progress report, a financial report and a list of publications based on the research must be submitted by the award recipient on or before January 31. Second-year funding is contingent upon submission of this documentation.
All publications, presentations and abstracts arising from work funded by this program must acknowledge support from the AGA Research Foundation R. Robert & Sally D. Funderburg Research Award in Gastric Biology.
AWARD OVERLAP If a candidate is granted the award and notified of a comparable award from another agency prior to the first payment of this award, the applicant must select one of the two awards. (i.e. the recipient may not retain both awards).
SELECTION CRITERIA The recipient will be selected based on novelty, feasibility and significance of the proposal. Preference will be given to novel approaches.
REVIEW PROCESS A selection committee composed of members of the AGA Research Awards Panel will review the proposals and determine the award recipient. Funding will commence in January.
APPLICATION PROCESS The application deadline date for this award is Aug 31. The completed application, letters of support or commitment and other documents, as applicable, must be combined into and submitted as one PDF document. The document must be titled by the applicant’s last name and first initial only. Hard copies are not accepted. Please e-mail the application document to awards@gastro.org. The applicant's full name and project title are to be included in the submission e-mail. Please direct all questions to the Research Awards Manager via telephone at 301-222-4012 or e-mail at awards@gastro.org.
Support for this award by the R. Robert and Sally D. Funderburg Charitable Trust is gratefully acknowledged.
American Society for Dermatologic Surgery Cutting Edge Research Grant Program
In 2012, up to $100,000 of grants will be awarded ranging from $2,500 to $20,000 per recipient. Awards will be announced at the ASDS Annual Meeting, October 11-14, 2012, in Atlanta, Georgia.
Research must be of specific relevance to dermatologic surgery and/or cutaneous oncology. This is a competitive award program for research projects not funded by other sources. This year, the ASDS Research Work Group has made a special request for investigator research into:
evidence-based medicine, comparative efficacy research, quality studies, and patient safety studies.
The Cutting Edge Research Grant Program unites education and innovation to encourage and stimulate clinical research and the transfer of new technologies from the research settings to surgical practice. Since 2000, the ASDS has awarded over $940,000 in clinical research funding in surgical oncology, lasers, botulinum toxins, fillers, liposuction and other cosmetic procedures.
Award Descriptions
The ASDS Research Work Group encourages submission of well-conceived research projects which stimulate the advancement of the practice of dermatologic surgery, the invention of new technologies, or research projects which document the outstanding and high volume work of dermatologic surgeons.
Up to $100,000 in funding will be awarded by the ASDS Research Work Group ranging in amounts from $2,500 - $20,000. Grants will be selected based on meeting the eligibility requirements and qualifications. Additionally, the Research Work Group will use the following criteria in its determination of awards:
Importance to dermatologic surgery Scientific validity Protocol quality Feasibility Suitability of research environment
Monies will be distributed in three installments to the sponsoring institution. Institutions or practices may submit only one application for consideration; multiple applications will automatically be rejected. This is a competitive award program for research projects not funded by other sources. The applicant retains ownership of intellectual property resulting from the clinical research funded by the ASDS.
Supported by generous contributions to the ASDS Dermasurgery Advancement Fund by our members and industry partners, the Cutting Edge Research Grant (CERG) program has been a resounding success for our Society and members. In 2012, grants ranging from $2,500 - $20,000 will be awarded again in order to stimulate a broad scope of research relevant to dermatologic surgeons and the dermatology specialty at-large.
The deadline for the 2012 Cutting Edge Research Grant program is July 9, 2012.
The American Society for Dermatologic Surgery (ASDS) was founded in 1970 to promote excellence in the subspecialty of dermatologic surgery and to foster the highest standards of patient care. The Society supports continuing education and training of its members, public information and community outreach programs relating to dermatologic surgery and this grant program.
For more information
Applicants with questions regarding the application process or the Cutting Edge Research Grant Program, in general, should contact the ASDS office.
American Society for Dermatologic Surgery 5550 Meadowbrook Drive, Suite 120 Rolling Meadows, IL 60008 Phone: 847-956-9124
Fax: 847-956-0999 Email applications to: sshelton@asds.net
James S. McDonnell Foundation Research Awards for Brain Cancer Research
Investigator-initiated research awards providing up to $450,000 for up to 6 years made to 501(c)(3) organizations in support of work done in Brain Cancer Research.
Deadline: March 14, 2012 15:59 CT. Apply online beginning February 15th.
21st Century Research Awards are designed to support research projects with a high probability of generating new knowledge and insights. Projects submitted for funding consideration should be at an early, even preliminary stage of development, and should be intended to break new ground or to revisit commonly-held assumptions. Projects submitted should be sufficiently cross-disciplinary or heterodox to have a strong likelihood of influencing the development of new ways of thinking about important problems.
21st Century Research Awards provide adequate, flexible funding over a sufficient time period to allow investigators to pursue and develop new directions to their research programs.
A maximum of $450,000 total costs can be requested and the funds can be expended over a minimum of 3 years to a maximum of 6 years. Please Note: Smaller amounts of money expended over shorter amounts of time may be requested to help investigators pursue pilot projects or test the feasibility of an experimental approach.
The applicant can apply the grant funds towards any research-based expense, including travel, equipment, and supplies. Funds can be used to support collaborative research projects. A percentage of the funds can also be used to support small workshops organized by the applicant where the goal of the workshop is to gather expertise in support of the research objective.
Grantee institutions must agree to waive all indirect and administrative costs.
Representatives of the Foundation will not advise applicants on the scientific merits or how well proposed projects fit the goals of JSMF grant programs. We believe these decisions are best made by potential applicant institutions after careful review all JSMF web-posted materials. All projects must qualify for one of the 21st Century Science Initiative's program area (see below) awarding 21st Century Initiative Research Awards.
Brain Cancer Research
The James S. McDonnell Foundation 1034 South Brentwood Blvd., Suite 1850 Saint Louis, MO 63117-1284 (314) 721-1532
NOTE: All applications and letters of inquiry should be sent electronically.
Travel Awards for Young Investigators and Developing Nations Investigators for the 15th World Conference on Lung Cancer
Travel Awards will be available for Young Investigators (35 years of age or younger) and Developing Nations Investigators. These awards will consist of complimentary registration to the Conference, up to five nights accommodation at one of the Conference contracted hotels, a fixed amount to help offset travel expenses and free membership in the International Association for The Study of Lung Cancer for one year.
If you fulfill all criteria for both awards, you may apply for both; however, if selected, you will only be offered one award.
HOW TO APPLY
The candidate must be the first author and presenter of the submitted abstract
Parts of the work can be presented prior to the 15th World Conference on Lung Cancer, but the submitted abstract MUST include new information not being presented prior to WCLC 2013
Abstracts must be submitted on or before the submission deadline June 21, 2013 via the online abstract submission form on the Conference website at www.2013worldlungcancer.org
Candidates must apply at the time of abstract submission via the online submission form on or before June 21, 2013. In addition the following support materials must be sent via email to the Conference Secretariat at wclc2013@icsevents.com. Please indicate your abstract number in your application materials.
Support Materials required for Young Investigator Award Application
Proof of age (35 years of age or younger) Curriculum Vitae Statement by the senior member (who must be a member of the IASLC) of the candidate's role in the research
Support Materials required for Developing Nations Award Application
Curriculum Vitae Description of your interest and current research in lung cancer (1 - 5 pages)
DEADLINES
The deadline for submission of applications including support materials is June 21, 2013. Applications received after June 21, 2013 or applications received without support materials by June 21, 2013 cannot be considered.
CONTACT
For any inquiries, please contact wclc2013@icsevents.com.
Certified Pediatric Oncology Nurse of the Year Award
This award recognizes a CPON or CPHON who has made significant contributions to pediatric oncology or hematology nursing; oncology nursing service; and who has supported and promoted oncology nursing certification. The Certified Pediatric Oncology Nurse of the Year will receive $1,000 and be presented with a crystal award at the Recognition Breakfast for Oncology Certified Nurses at the APHON Annual Conference.
Application Deadline: April 1
Award Criteria Nominees must demonstrate accomplishments in the promotion of oncology nursing certification; and oncology nursing service; as well as in one of the following areas of pediatric oncology or hematology nursing; clinical practice, education, or research.
Promotion of Oncology Nursing Certification
Actively promotes oncology nursing certification among nursing colleagues, other healthcare professionals, and healthcare consumers
Service
Enhances the image of oncology nursing among the general public Participates in community affairs, legislative activities, or in organizations that affect nursing Enhances the image of oncology nursing among healthcare professionals Participates in community education Pediatric Oncology or Hematology Nursing Practice
Candidates must demonstrate accomplishments in ONE of the following areas (nominee, nominator, and recommendations must all address the same area):
Clinical Practice Develops or uses creative approaches to pediatric oncology or hematology nursing which enhance quality patient care Serves as an example to inspire pediatric oncology or hematology nurse peers Demonstrates a commitment to the care of persons with cancer and their families
Education Participates in the education and development of nurses Participates in patient/family teaching Participates in educating other disciplines about pediatric oncology or hematology nursing
Research Participates in the research process Applies research findings to nursing practice Conducts research which positively affects pediatric oncology or hematology patient care
Eligibility Criteria
Nominees must be CPON® or CPHON™ certified at the time of nomination and award presentation. Nominees must be currently licensed as RNs (or possess equivalent foreign credentials). Members of the ONCC Recognition Subcommittee and the ONCC Board of Directors are not eligible to be nominees, to nominate others, or to provide recommendations for nominees.
In addition:
Each nomination must include completed Nomination Information, Biographical information, and two Recommendations/Letters of Reference.
The two Recommendations/Letters of Reference must be from individuals other than the nominator or nominee. Only two Recommendations may be submitted; additional recommendations will not be considered.
All materials must be submitted online. It will be the responsibility of the Nominator or Nominee (if a self-nomination) to provide the requested information, and to upload the supporting References/Letters of Recommendation with the online application.
Completed nominations must be submitted by April 1.
Incomplete or late nominations will not be considered.
Additional materials or supporting documentation will not be considered.
All decisions of the ONCC Recognition Subcommittee and ONCC Board of Directors are final.
Award recipients must agree to be recognized in ONCC Certification News, and/or other publications approved by ONCC.
123next
